(Q36204670)

12 August 2017

NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice (English)

1 reference

12 August 2017

Stephen J Price

1

0 references

author name string

Ian R Whittle

2

1 reference

12 August 2017

Keyoumars Ashkan

3

1 reference

12 August 2017

Paul Grundy

4

1 reference

12 August 2017

Garth Cruickshank

5

1 reference

12 August 2017

UK-HGG Study Group

6

1 reference

12 August 2017

6 April 2012

1 reference

British Journal of Neurosurgery

12 August 2017

1 reference

12 August 2017

26

1 reference

12 August 2017

3

1 reference

12 August 2017

331-335

1 reference

Chemotherapy wafers for high grade glioma

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

The 2007 WHO classification of tumours of the central nervous system

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Surgery for malignant gliomas: mechanistic reasoning and slippery statistics

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Gliadel therapy given for first resection of malignant glioma: a single centre study of the potential use of Gliadel

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432583

Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience

1 October 2017

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F02688697.2012.673651

Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22482926

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Multidisciplinary team working in cancer: what is the evidence?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22482926

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3109/02688697.2012.673651

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22482926

1 reference